The type I human T-cell leukemia virus (HTLV-I) induces abnormal growth and subsequent transformation of T cells, which is associated with the development of an acute T-cell malignancy termed adult T-cell leukemia. A characteristic of HTLV-I-transformed T cells is the constitutive nuclear expression of NF-kB/Rel family of transcription factors, which appears to be essential for the growth of these transformed cells. Although NF-kB/ Rel factors are known to induce the expression of T-cell growth factor interleukin (IL)-2, it is unclear how they participate in the IL-2-independent growth of HTLV-Itransformed cells. In this study, we show that certain NF-kB/Rel members, predominantly c-Rel, interact with enhancer sequences for STAT5, a key transcription factor mediating IL-2-induced T-cell proliferation. Reporter gene assays reveal that the binding of c-Rel to the STAT5 site present in the FcgR1 gene leads to potent transactivation of this enhancer. Binding of c-Rel to the FcgR1 STAT site also occurs in human peripheral blood T cells immortalized with HTLV-I in vitro and is correlated with enhanced levels of proliferation of these cells. These results raise the possibility that NF-kB/Rel may participate in the growth control of HTLV-Itransformed T cells by regulating genes driven by both kB and certain STAT enhancers.
Introduction
The proliferation of normal T cells is tightly controlled by various cytokines, most importantly interleukin-2 (IL-2), which is produced as a result of antigen-mediated activation of resting T cells (Schwartz, 1990) . Binding of cytokines to their cell surface receptors triggers a cascade of signal transduction events leading to the activation of various protein tyrosine kinases (PTK), including members of the Janus kinase (JAK) family (Johnston et al., 1994; Witthuhn et al., 1994) . The JAKs then phosphorylate and induce the dimerization and nuclear translocation of a family of enhancer binding proteins termed signal transducers and activators of transcription (STAT) (Darnell et al., 1994; Ihle, 1996; Schindler and Darnell, 1995) . The STAT factors function by binding to an enhancer element termed interferon gamma-activated site (GAS) that is present in the promoter regions of various cytokine-regulated genes (Darnell et al., 1994; Ihle, 1996; Schindler and Darnell, 1995) . The distinct biological eects of dierent cytokines appear to be mediated, at least partially, by the activation of speci®c STAT factors (Ihle, 1996) . Dierent STAT factors in turn recognize distinct GAS sequences and regulate dierent target genes (Ihle, 1996; Lin et al., 1995; O'Shea, 1997) . In lymphoid cells, IL-2 is known to induce STAT5 as well as STAT3 (Fujii et al., 1995; Johnston et al., 1994 Johnston et al., , 1995 Witthuhn et al., 1994) .
While the proliferation of normal T cells largely relies on the action of IL-2, under certain situations T cells may undergo proliferation even in the absence of IL-2. One example is seen with T cells infected with the type I human T-cell leukemia virus (HTLV-I), the etiologic agent of an acute and often fatal T cell malignancy termed adult T-cell leukemia (ATL) (Poiesz et al., 1980; Yoshida et al., 1982) . HTLV-I preferentially infects CD4 + T cells, enabling them to undergo spontaneous proliferation in vitro, even though these cells rarely produce IL-2 (HoÈ llsberg et al., 1992) . Precisely how HTLV-I induces the IL-2-independent proliferation of T cells remains elusive. However, emerging evidence suggests that deregulation of various cellular transcription factors by the virus may play an important role (Ressler et al., 1996) . In this regard, HTLV-I encodes a transactivator protein termed Tax, which activates or enhances the activity of a number of cellular transcription factors, including members from the NF-kB/Rel families (Smith and Greene, 1991; Yoshida, 1995) . The nuclear expression of NF-kB/Rel appears to be essential for the growth of both Tax-transformed murine ®broblasts and HTLV-Itransformed human T cells (Akagi et al., 1997; Kitajima et al., 1992; Yamaoka et al., 1996) .
The NF-kB/Rel family is composed of at least ®ve members, including p50, p52, RelA, RelB and the proto-oncoprotein c-Rel (reviewed in Gilmore, 1990; Siebenlist et al., 1994) . In normal T cells, as in many other cell types, the biological activity of NF-kB/Rel is tightly regulated through its cytoplasmic retention by speci®c inhibitory proteins termed IkB (Beg and Baldwin, 1993) . Activation of NF-kB/Rel by immunological and mitogenic signals involves the induction of IkB phosphorylation and proteolysis, allowing the released NF-kB/Rel factors to enter the nucleus (Beg and Baldwin, 1993; Stancovski and Baltimore, 1997) . Interestingly, Tax can induce the persistent phosphorylation and degradation of the IkB molecules, resulting in the constitutive nuclear expression of NF-kB/Rel (Brockman et al., 1995; Good and Sun, 1996; Kanno et al., 1994; Lacoste et al., 1995; McKinsey et al., 1996; Sun et al., 1994) . Among the NF-kB/Rel factors, c-Rel is a predominant form in HTLV-I-transformed T cells (Li et al., 1993) . Although c-Rel is clearly required for transcriptional activation of the IL-2 genes (KoÈ ntgen et al., 1995) , it is unclear how the Rel protein participates in the growth control of HTLV-I-transformed cells.
In addition to NF-kB/Rel, recent studies have shown that certain STAT factors are constitutively activated in some HTLV-I-transformed T-cell lines Mulloy et al., 1998; Takemoto et al., 1997) . Thus, the deregulated expression of STAT target genes may contribute to HTLV-Iinduced IL-2-independent T-cell proliferation. In the present study, we show that members of the NF-kB/ Rel family, especially c-Rel, can also bind to the target DNA sequence of STATs and transactivate STAT-speci®c reporter genes. These ®ndings raise the intriguing possibility that NF-kB/Rel factors may participate in the regulation of certain STAT target genes.
Results

Constitutive activation of GAS-binding nuclear factors in HTLV-I-transformed T cells
To investigate whether constitutive activation of STAT factors is a common feature for HTLV-I-transformed T cells, EMSA was performed to examine the FcgR1 GAS-binding activity in a number of IL-2-independent HTLV-I-transformed human T-cell lines. As shown in Figure 1 , no signi®cant DNA binding activity was detected from the extracts of normal resting peripheral blood lymphocytes (PBL, lane 1) or the HTLV-Inegative Jurkat leukemic T cells (lane 2). In contrast, strong GAS-binding activity was detected (C1 and C2) from each of the HTLV-I-transformed cell lines, including MT2 (lane 3), C8166 (lane 4), HUT102 (lane 5), and SLB-1 (lane 6). We then analysed the composition of the GAS-binding protein complexes using antibody`supershift' assays. As previously reported , the GAS-binding factors from the MT-2 cells included both STAT5 and STAT3, since one of the complexes (C1) was supershifted by antisera speci®c for human STAT5 (Figure 2 , lane 2) and STAT3 (lane 3) but not by a preimmune serum (lane 4). Using the same strategy, STAT5, although not STAT3, was also detected from HUT102 cells (lanes 5 ± 7). Unexpectedly, however, neither anti-STAT5 nor anti-STAT3 immunoreacted with the C2 complex detected from C8166 (lanes 8 ± 10), SLB-1 (11 ± 13), as well as the MT-2 and HUT102 cells (lanes 1 ± 7, C2). The c-Rel proto-oncoprotein is a predominant GAS-binding factor in HTLV-I-transformed T cells
To examine the molecular nature of the C2 complex, supershift assays were performed using antibodies speci®c for various transcription factors known to be activated in HTLV-I-transformed T cells (Figure 3) . Antisera for the p50 and p52 subunits of NF-kB/Rel partially supershifted the C2 complex detected in C8166 cells (Figure 3a , lanes 4 and 5), while no immunoreactivity was observed with a preimmune serum (lane 8) or antisera for RelA (lane 6), STAT3 (lane 3) and STAT5 (lane 2). Remarkably, the entire GAS-binding complex was supershifted by a peptidespeci®c antibody for c-Rel (lane 7). We noticed that a weak and more slowly migrating complex could be occasionally detected in our EMSA (Figure 3a , arrowhead). This complex, which migrated slightly faster than the STAT5-containing C1 complex (data not shown) had no immunoreactivity with the antibodies for STAT5 ( 
c-Rel preferentially binds to STAT5-speci®c GAS-related sequences
We then performed oligonucleotide competition assays to compare the DNA binding speci®city of c-Rel and STAT. For these studies, we used a nuclear extract isolated from the MT-2 cells since it contained DNA binding activity of both STAT5 and c-Rel (see Figures 2 and 3b). As expected, the binding of STAT5 to the 32 P-labeled FcgR1 GAS probe was completely abrogated when excess amounts (50-or 100-fold molar excess) of the same probe was added to the EMSA reaction ( Figure 4b , lanes 2 and 3, upper band). Similarly, formation of the c-Rel complex was also blocked under these conditions (lanes 2 and 3, lower band).
The eciency of competition for the STAT5-and cRel-DNA complexes was similar, suggesting that these two factors have similar binding anity to the FcgR1 GAS sequence. However, STAT5 and c-Rel appeared to have markedly dierent binding anity to the IL2Ra kB site, as this probe selectively competed the formation of the c-Rel/GAS complex but had no obvious eect on formation of the STAT5/GAS a b c Figure 3 The proto-oncoprotein c-Rel is a predominant GASbinding factor in HTLV-I-transformed T cells. (a) Antibody supershift analyses of the GAS-binding complex detected from C8166 cells. EMSA was performed in the absence (none) or presence of the indicated preimmune or speci®c antisera. The arrowhead indicates a complex migrating more slowly than C2 (but faster than C1). Both this faint complex and C2 weakly immunoreacted with antisera for p50 (lane 4) and p52 (lane 5) and were completely supershifted by the anti-c-Rel antiserum (lane 7). (b) Antibody supershift assays were performed as described in a using nuclear extracts of the indicated cells. (c) Antibody supershift analyses of the GAS-binding complexes from IL-2-stimulated HT-2 cells complex (Figure 4b, lanes 16 and 17) . To compare the binding anity of c-Rel to the two dierent probes, a parallel competion assay was performed using the 32 Pradiolabeled IL-2Ra kB as probe and unlabeled FcgR1 GAS ( Figure 4c , lanes 2 ± 4) or IL-2Ra kB (lanes 5 ± 7) as competitors. The kB sequence (lane 5 ± 7) exhibited signi®cantly higher competition eciency than the GAS sequence (lanes 2 ± 4). Thus, it appears that cRel and STAT5 bind to the GAS sequence with similar anity, whereas c-Rel has much higher kB binding anity than STAT5.
The DNA binding speci®city of STAT5 and c-Rel was examined by performing competition assays with a probe harboring base changes. When three cytidines were mutated to guanines at the core region of the FcgR1 GAS site (Figure 4a , FcgR1 Mut, underlined bases), it abolished the ability of this oligonucleotide to compete for binding to STAT5 as well as to c-Rel (lanes 18 and 19). These results suggested that the binding of both STAT5 and c-Rel to this probe was highly speci®c and that these two factors may bind to the same or overlapping sites in the FcgR1 sequence. To investigate whether c-Rel also binds to other STAT target sequences, the ability of various GAS-related sequences to compete with the FcgR1 probe for binding to c-Rel was analysed. In this regard, prior studies have shown that dierent STAT factors may bind to distinct GAS elements (Ihle, 1996; O'Shea, 1997) . For example, STAT5 speci®cally binds to the FcgR1, IRF-1 and APRE GAS sites but not to other GAS-like sequences, such as Ly6E, Ie, SIE and ISRE (Mui et al., 1995) , (see Figure 4a for sequence information). Consistent with the previous studies, formation of the STAT5 complex was markedly inhibited by the IRF-1, APRE, as well as FcgR1, GAS sequences (lanes 2 ± 7). More importantly, the binding of c-Rel was also eciently competed (lanes 2 ± 7). On the other hand, none of the Ie group of GAS sequences (Ie, Ly6E, SIE and ISRE) competed the formation of the STAT5 or c-Rel complexes (lanes 8 ± 15). Thus, c-Rel appears to speci®cally recognize the GAS sequences for STAT5.
Transfected c-Rel binds to and transactivates the FcgR1 GAS element
To evaluate the functional importance of c-Rel binding to GAS sequence, the eect of c-Rel on transcriptional activity of the FcgR1 GAS element was analysed by reporter gene assays. As shown in Figure  5a , transiently expressed c-Rel bound to the GAS sequence and formed a DNA-protein complex ( Figure  5a , lane 2), which could be supershifted by the anti-cRel antibody (data not shown). This ®nding con®rmed the ability of c-Rel to bind to the GAS sequence. Furthermore, this speci®c DNA binding activity of cRel requires its N-terminal sequences, since deletion of 32 amino acids from the N-terminus of c-Rel generated a mutant (33 ± 587) de®cient in the GAS binding (Figure 5a EMSA was performed using the radiolabeled wildtype FcgR1 GAS probe and MT-2 nuclear extract either in the absence (7) or presence of the indicated amounts (fold molar excess) of various unlabeled oligonucleotide probes. The identity of the STAT5-and c-Rel-containing complexes was determined by antibody supershift assays (data not shown, also see Figures 2 and 3b) . (c) Competition assays were performed using radiolabeled IL-2Ra kB probe and C8166 nuclear extract either in the absence (7) or presense of the indicated amounts (fold molar excess) of the indicated unlabeled oligonucleotide probes sequences (Figure 5b, column 2) . Consistent with its de®ciency in DNA binding, the c-Rel N-terminal deletion mutant (33 ± 587) failed to transactivate the GAS reporter (column 4). Although the C-terminal deletion mutant of c-Rel was able to bind the GAS sequence (Figure 5a ), this mutant did not transactivate the reporter (Figure 5b, column 3 ). This result was in agreement with the ®nding that the C-terminal portion of c-Rel contains its transactivation domain (Doerre et al., 1993) . Thus, the protooncoprotein c-Rel serves as a potent transcriptional activator of the GAS enhancer element, and this function of c-Rel requires both its N-terminal DNA binding and C-terminal transactivation domains. We also examined the eect of RelA on the transcriptional activity of the GAS enhancer ( Figure 5c ) and showed that RelA exhibited much lower GAS transactivation activity than c-Rel, although RelA is a stronger activator of the kB enhancer (data not shown). This result is consistent with the ®nding that c-Rel is the predominant GAS binding NF-kB component in both HTLV-I-infected cells and cells transiently expressing c-Rel and RelA (Figure 3a and data not shown).
Induction of GAS-binding factors correlates with HTLV-I-induced T-cell proliferation
To examine the physiological relevance of our ®ndings obtained with individual HTLV-I-transformed cell lines, we tested whether GAS-binding factors are also induced along with HTLV-I-induced T cell transformation. For these studies, bulk human peripheral blood T cells were immortalized with HTLV-I by in vitro cultivation with g-irradiated HTLV-I donor cells (MT-2). As previously reported (Persaud et al., 1995) , proliferation of the newly immortalized T cells stringently requires exogenous IL-2, but they become less IL-2 dependent and proliferate in the presence of suboptimal amounts of exogenous IL-2 after about 4 months in culture (data not shown). Although long term cultivation of these cells required exogenous IL-2, these cells could proliferate in the absence of IL-2 or mitogenic stimuli for short periods (up to 96 h, Figure  6a and data not shown). In sharp contrast, the normal uninfected T cells did not proliferate unless stimulated with mitogens ( Figure 6a ). Similar IL-2-independent growth was previously also demonstrated with HTLV-I-infected antigen-speci®c T-cell clones (HoÈ llsberg et al., 1992).
We then analysed the GAS-binding activity in both the normal and HTLV-I-immortalized T cells by EMSA using the FcgR1 GAS element as probe. In IL-2-starved normal T cells, no GAS-binding activity was detected (Figure 6b , lane 1). Upon stimulation with the mitogens, GAS-binding factors were clearly induced (lanes 2 and 3). Antibody supershift assays showed that the GAS-binding complexes formed in normal T cells treated for 8 h were supershifted by antibodies for both STAT5 (Figure 6c , lane 2) and cRel (lane 3), but did not react with a preimmune serum (lane 1) or an unrelated immune serum (anti-NF-ATp, lane 4). Thus, the mitogen stimulated T-cell proliferation was correlated with the induction of GAS-binding factors including both STAT5 and cRel. Interestingly, strong GAS-binding activity was detected in the untreated HTLV-I-immortalized T cells (Figure 6b, lane 4) . Stimulation of these cells with PHA did not signi®cantly alter the pattern of the GAS-binding complex formation (data not shown). a Figure 5 Transfected c-Rel binds to and transactivates the FcgR1 GAS enhancer. (a) Binding of c-Rel to FcgR1 GAS. COS cells were transfected with either a parental pCMV4 plasmid vector (lane 1) or the pCMV4-based cDNA expression vectors encoding wildtype or mutant forms of c-Rel. After 40 h nuclear extracts were isolated from the transfectants, the GAS binding activity was analysed by EMSA. The expression of c-Rel and its mutants was con®rmed by a parallel immunoblotting assay using a peptide-speci®c anti-c-Rel antibody (data not shown). (b) Activation of a GAS-driven reporter by c-Rel. F9 cells were transfected with a luciferase reporter driven by the FcgRI STAT enhancer (GRR-STAT-Luc) along with either the parental vector pCMV4 or cDNA expression vectors encoding the wildtype or truncated forms of c-Rel. After 40 h, cell extracts were prepared and assayed for luciferase activity. Luciferase activity is presented as fold induction relative to the basal level measured in cells transfected with pCMV4 (7970 c.p.m.) . The values shown are means+standard errors from three independent experiments. (c) RelA is a weak GAS transactivator. F9 cells were transfected with the GRR-STAT-Luc along with either pCMV4 or expression vectors encoding c-Rel or RelA. Luciferase activity was measured as described in b Supershift assays revealed that these complexes contained predominantly c-Rel (Figure 6c , lane 7) but only low amounts of STAT5 (lane 6). These results suggested that the IL-2-independent proliferation of HTLV-I-immortalized T cells was correlated with the enhanced binding of c-Rel to the STAT5 target enhancer.
Discussion
Antigen-stimulated T-cell growth is tightly controlled by the inducible secretion of IL-2 and the expression of its high anity receptor. The binding of IL-2 to its receptor triggers activation of protein tyrosine kinases, including JAKs, which in turn activate the nuclear . These factors activate target genes driven by the GAS enhancer element, thus contributing to IL-2-induced cell proliferation. Infection of T cells with HTLV-I is associated with an initial phase of IL-2-dependent polyclonal cell growth, which is believed to facilitate occurrence of secondary events allowing the infected cells to progress to an IL-2-independent stage. The mechanism mediating the IL-2-independent growth of HTLV-I-transformed cells is elusive. However, it is generally believed that deregulation of cellular transcription factors and abnormal induction of their target genes may play a role (Ressler et al., 1996) . In this regard, recent studies have shown that the JAK/STAT system is constitutively activated in certain HTLV-Itransformed T cell lines Takemoto et al., 1997; Xu et al., 1995) , thus suggesting that constitutive STAT activation may play a role in HTLV-I-induced IL-2-independent T-cell growth. However, it has recently been shown that STAT activation does not occur in T cells transformed by HTLV-II (an HTLV-I related virus) or the Tax protein of HTLV-I (Mulloy et al., 1998) . Even some of the HTLV-I-transformed T-cell lines lack detectable JAK/STAT activity (Mulloy et al., 1998 and this study). These ®ndings suggest the involvement of additional mechanisms in HTLV-I-induced cell growth. The NF-kB/Rel enhancer binding proteins have also been implicated in the growth control of HTLV-Itransformed cells. These factors are constitutively activated almost exclusively in HTLV-I-and Taxtransformed cells (Ressler et al., 1996) . Inhibition of NF-kB/Rel expression using speci®c antisense oligonucleotides potently interferes with the growth of tumor cells induced by both HTLV-I and Tax (Kitajima et al., 1992) . It has not been de®ned how NF-kB/Rel participates in the growth control of HTLV-Itransformed cells. A known mechanism for c-Relinduced normal T-cell proliferation is the induction of IL-2 and its high anity receptor (KoÈ ntgen et al., 1995) , which in turn triggers the activation of various growth-regulatory factors, including STAT5. However, except during the early stage, the HTLV-I-transformed T cells usually do not produce IL-2 nor require IL-2 for growth (HoÈ llsberg et al., 1992; Uchiyama, 1997) . Our data may suggest a potential mechanism by which NF-kB/Rel participates in the control of IL-2-independent T-cell growth. We have demonstrated that certain NF-kB/Rel members, especially c-Rel, are able to functionally interact with target enhancers (GAS) of STAT5. Remarkably, c-Rel serves as a predominant GAS-binding factor in a number of HTLV-I-transformed T-cell lines analysed. Because of the contribution of c-Rel, the GAS site is constitutively occupied in all these HTLV-I-transformed cell lines, even though STAT5 and STAT3 are only activated in some of them (Figure 1 ). These results are in agreement with a recent protein structural study, which demonstrates that STAT and the Rel proteins share striking structural similarity even though they have no obvious sequence homology (Becker et al., 1998) . However, it is suggested that STAT and Rel proteins dier in their DNA binding constants, which are in the nanomolar and picomolar ranges for STATs and Rel proteins, respectively (Becker et al., 1998) . Our competition assays also show that c-Rel appears to have higher anity to the IL-2Ra kB site compared to its binding anity to the FcgR1 GAS sequence ( Figure  4c) . Nevertheless, the binding of c-Rel to the GAS enhancer is functional since c-Rel potently activates a luciferase reporter gene driven by the FcgR1 GAS in transiently transfected cells (Figure 5b ). Given its abundant expression in HTLV-I-transformed T cells, c-Rel may participate in the activation of certain STAT5 target genes in these virus-infected cells.
A recent study suggests that STAT6 physically interacts with the p50 and RelA subunits of NF-kB and functionally cooperate with NF-kB in IL-4-induced transcription (Shen and Stavnezer, 1998) . However, we have not been able to detect interaction between c-Rel and STAT5 using either co-immunoprecipitation or antibody supershift assays (Figure 6c and data not shown). Of course, our data can not exclude the possibility that these two growth-related transcription factors function cooperatively on certain gene promoters.
Materials and methods
Cells and culture conditions
Human Jurkat leukemic T cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and antibiotics (complete RPMI). Murine HT2 cells were cultured in complete RPMI medium supplemented with 25 units of human recombinant IL-2 (Biological Resources Branch, NCI) and 55 mM b-mercaptoethanol. F9 embryonal carcinoma cells were cultured in Iscove's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, and antibiotics (complete Iscove's medium). C8166 (Salahuddin et al., 1983) , HUT102 , MT-2 (Miyoshi et al., 1981) and SLB-1 (Koeer et al., 1984) are HTLV-Itransformed human T-cell lines, which proliferate independent of IL-2. The C8166, HUT102 and MT-2 cells were cultured in complete RPMI medium, and the SLB-1 cells were maintained in complete Iscove's medium. Human peripheral blood mononuclear cells (PBMC) were prepared from T-cell enriched human blood (Biological Specialty Corporation, Colmar) with a Ficoll-Hypaque gradient (Pharmacia Biotech). The cells were stimulated for 36 h with phytohemaglutinin (PHA, 2 mg/ml) and then cultured in RPMI 1640 medium supplemented with 20% fetal bovine serum, 2 mM L-glutamine, antibiotics and 25 units/ml of human recombinant IL-2. Under these conditions, PBMC usually continuously grew for 2 ± 4 weeks in the presence of exogenous IL-2. Proliferating T cells were isolated from the PBMC by negative selection using the Enrichment Immunecolums (Biotex Laboratories Inc., Edmonton, Alberta). For obtaining resting PBMC or T cells, the cells were washed twice with RPMI lacking IL-2 followed by incubating the cells in the same medium for 24 ± 30 h.
In vitro immortalization of T cells with HTLV-I
In vitro immortalization of T cells with HTLV-I was performed as previously described (Merl et al., 1984; Persaud et al., 1995) . Brie¯y, PHA-stimulated PBMC was cocultured with g-irradiated HTLV-I donor cells (MT-2) in the IL-2-containing RPMI medium. The cells were diluted when the medium become acidic (as indicated by its color change). As controls, PBMC and g-irradiated MT-2 cells were cultured separately under the same conditions. As expected (Merl et al., 1984; Persaud et al., 1995) , immortalized T cells started dominating the PBMC/MT-2 coculture after 4 ± 5 weeks. These immortalized cells were continuously proliferating when exogenous IL-2 was provided, a characteristic of T cells at early stage of HTLV-I infection (Feuer and Chen, 1992; Sodroski, 1992) . Under the same culturing conditions, the uninfected control PBMC usually cease growth between 2 ± 4 weeks, and the g-irradiated MT-2 cells never grew (data not shown). The HTLV-I-immortalized T cells were maintained in RPMI medium supplemented with IL-2 and used as bulk population after about 4 months. Normal T cells were collected after 1 ± 2 weeks of cultivation and frozen in RPMI supplemented with 10% dimethyl sulfoxide until use. To re-start the culture, the frozen cells were washed once with RPMI medium and then cultured in the same medium supplemented with IL-2.
Nuclear extract preparation and electrophoresis mobility shift assay (EMSA)
Normal human peripheral blood T cells and HTLV-Iimmortalized T cells were starved for 30 h in RPMI growth medium lacking exogenous IL-2. The cells were either not treated or incubated with PMA (10 ng/ml) plus PHA (1 mg/ ml) for the indicated times and then subjected to nuclear extract preparation. Jurkat, HT2 and IL-2-independent HTLV-I-transformed T cell lines were collected directly from their culturing media. Nuclear extracts were prepared from these cells as previously described (Schreiber et al., 1989) . Human 293 cells were transfected using DEAEdextran (Holbrook et al., 1987) with cDNA expression vectors encoding the wildtype or mutant forms of c-Rel (Doerre et al., 1993) and collected for nuclear extract preparation 40 h after transfection. EMSA was performed by incubating nuclear extracts isolated from the various cell types (*10 mg for untransfected T cells and *5 mg for transfected 293 cells) with 32 P-radiolabeled wildtype FcgR1 STAT probe (Figure 3a , FcgR1WT) at room temperature for 10 min followed by resolving the DNA-protein complexes on native 5% polyacrylamide gels (Ganchi et al., 1992) . For antibody`supershift' assays, 0.5 ml of antisera for NF-kB or STAT proteins (Santa Cruz, Inc.) were added to the EMSA reaction 5 min before electrophoresis. Competition assays were performed by including excess unlabeled double stranded oligonucleotide probes in the reaction. Oligonucleotide probes used in EMSA and competition assays are indicated in Figure 4a .
Luciferase reporter gene assays F9 cells were seeded onto 0.1% gelatin-treated, 24-well plates (5610 4 cells/well) 1 day before transfection. The cells were transfected using LIPOFECTAMINE TM reagent (Gibco BRL) with one mg of a luciferase reporter driven by the FcgRI STAT enhancer (GRR-STAT-Luc, ref. Nakajima et al., 1996) along with 0.125 mg of cDNA expression vectors encoding wildtype or truncated forms of c-Rel or RelA. Cell extracts were prepared and assayed for luciferase activity (Promega) 40 ± 48 h after transfection.
Cell proliferation assays
Normal or HTLV-I-infected human T cells were starved for 30 h in RPMI media lacking IL-2. The cells were aliquoted into a 96-well plate and either not treated or stimulated with PMA (10 ng/ml) plus PHA (1 mg/ml). After 24 ± 72 h, proliferation of the cells were determined by incubating the cells with a non-radioactive proliferation assay reagent (Promega, CellTiter 96 AQ One) for about 1 h followed by measuring the absorbance at 490nm using an ELISA plate reader.
